glp 1 6 in one A new oral GLP-1 option is now part of obesity medicine. FDA approved Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist, for adults with obesity or overweight with at least weight-related GLP-1 Six in One Oral
Pay in 4 interest-free payments of $7.44 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24


















:max_bytes(150000):strip_icc()/Health-GettyImages-2219827987-cf32483d6c854df0ba239114420da85b.jpg)








